Clinical Research Directory
Browse clinical research sites, groups, and studies.
Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
Sponsor: CVRx, Inc.
Summary
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Official title: Neo Non-Randomized Hypertension Study
Key Details
Gender
All
Age Range
21 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2011-06
Completion Date
2026-08
Last Updated
2025-07-15
Healthy Volunteers
No
Conditions
Interventions
BAROSTIM NEO System
Medical Management
Locations (9)
University of Calgary
Calgary, Alberta, Canada
University of Alberta - Edmonton
Edmonton, Alberta, Canada
London-Lawson Health Research Institute
London, Ontario, Canada
University Hospital Cologne
Cologn, Germany
University Hospital Duesseldorf
Düsseldorf, Germany
Goettingen-Georg August University
Göttingen, Germany
Midizinische Hochschule Hannover
Hanover, Germany
Klinkum St. George Leipzig
Leipzig, Germany
Maastricht University
Maastricht, Netherlands